Wired reporter Megan Molteni writes that MIT researchers have developed an ingestible capsule that could be used to deliver insulin to diabetes patients. The researchers were inspired by the leopard tortoise to create a self-orienting device that can position itself to deliver medication directly into the stomach. “The result was a roly-poly-pill that autonomously rights itself to be needle-down,” Molteni explains.
Associated Press reporter Lauran Neergaard writes that MIT researchers have created a pea-sized pill that, once swallowed, can deliver medications such as insulin directly to the stomach. “The way this works is it travels down the esophagus in seconds, it’s in the stomach within a few minutes, and then you get the drug,” explains visiting scientist Giovanni Traverso.
Inspired by the shell of a leopard tortoise, MIT researchers have developed a self-orienting ingestible capsule that can deliver doses of medication to the stomach, writes Megan Thielking for STAT. “If we’re able to deliver large molecules orally, it would not only change drug delivery but also drug discovery,” says Prof. Robert Langer.
A team of MIT researchers has created a tiny ingestible device that deliver medications such as insulin directly to the stomach and could replace the daily injections used to treat diabetes patients, reports Alice Park for TIME. “We see no reason why someday this couldn’t be used to deliver any protein to the body,” says Prof. Robert Langer.
Boston Globe reporter Martin Finucane writes that MIT researchers have developed an ingestible capsule that contains a small needle that injects insulin directly into the stomach. Finucane writes that the researchers “designed the pill with a special shape to ensure that it will fall and then orient itself at the bottom of the stomach so that the needle is facing toward the stomach lining rather than the stomach’s inside.”
Xinhua reports that MIT researchers have “discovered that lung tumors could hijack bacteria within the lung to promote their own survival.” As Tyler Jacks, director of the Koch Institute and the paper’s senior author explains, this research "opens up multiple potential avenues toward lung cancer interception and treatment.”
MIT researchers have developed a new ingestible pill that expands once it reaches the stomach and could be used to monitor a patient’s health, reports the BBC News. “The dream is to have a smart pill, that once swallowed stays in the stomach and monitors the patient's health for a long time, such as a month,” explains Prof. Xuanhe Zhao.
STAT reporter Casey Ross writes about how MIT researchers have developed a new ingestible Prof. Timothy Lu explains that he hopes that the sensor “opens up a really new window into how the gut and the rest of the body are connected, and hopefully provide new diagnostic strategies as well.”
New York Times reporter Steve Lohr writes about the MIT AI Policy Conference, which examined how society, industry and governments should manage the policy questions surrounding the evolution of AI technologies. “If you want people to trust this stuff, government has to play a role,” says CSAIL principal research scientist Daniel Weitzner.
Guardian reporter Ian Sample writes that MIT startup Synlogic are developing a “living” medicine” made from genetically modified bugs. “By engineering these bacteria, we are able to control how they operate in the human gastrointestinal tract,” says Caroline Kurtz of Synlogic. “It allows us to think about many other diseases where you may need to produce something beneficial, or remove something that is toxic for the patient.”
MIT researchers have developed an inhalable form of messenger RNA that could be used to help treat patients with lung disease, reports Christopher Intagliata for Scientific American. Intagliata explains that researchers hope to one day “use this technique to help cystic fibrosis patients.”
CBS Boston reporter Dr. Mallika Marshall spotlights research by researchers at MIT and Brigham and Women’s Hospital to develop robotic prosthetic limbs controlled by the brain. “It’s a wonderful experience as a researcher,” explains Herr of the work’s impact. “They walk away and start crying or laughing and giggling and say, ‘my gosh I have my body back, I have leg back, I have my life back.’”
MIT researchers have developed a remote-controlled ingestible capsule that can be operated by a user’s smartphone, reports the Xinhua news agency. “The researchers envisioned that this type of sensor could be used to diagnose early signs of disease and then respond with the appropriate medication,” Xinhua explains.
HealthDay News reporter E.J. Mundell writes that MIT researchers have developed an ingestible capsule that can be used to monitor health a patient’s health. “The capsule could deliver drugs as well as sense the condition of its surroundings in the gut, including infections or allergic reactions,” Mundell explains.
MIT researchers have engineered wasp venom to kill bacteria, reports Chukwuma Muanya for The Guardian. The researchers found that the altered peptides wiped out the antibiotic-resistant bacteria Pseudomonas aeruginosa within four days.